Vandenberghe et al. constructed a new deep learning approach to identify the HER2 biomarker for breast cancer to identify high-risk misdiagnosis cases and thus assist in clinical decision making for breast cancer diagnosis [31]. This evidence concerns the gene ERBB2 and breast cancer.